Trial intelligence / Profile preview

Prosaptide for HIV-associated neuropathic pain

NCT00286377Phase 2Terminated

Sponsor
Savient Pharmaceuticals
Start
Sep 2003
Modality
Peptides, Small Molecules
01

Overview

A Phase 2 trial of prosaptide in neuropathic pain, sponsored by Savient Pharmaceuticals. Started Sep 2003; status: terminated.

02

Drugs

prosaptide
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT00286377.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00286377.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call